Henry Schein (HSIC) to Release Earnings on Tuesday

Henry Schein (NASDAQ:HSIC) is scheduled to release its earnings data before the market opens on Tuesday, May 7th. Analysts expect the company to announce earnings of $0.99 per share for the quarter. Henry Schein has set its FY 2024 guidance at 5.000-5.160 EPS and its FY24 guidance at $5.00 to $5.16 EPS.Investors interested in registering for the company’s conference call can do so using this link.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings data on Tuesday, February 27th. The company reported $0.66 earnings per share for the quarter, missing the consensus estimate of $0.70 by ($0.04). The company had revenue of $3.02 billion during the quarter, compared to the consensus estimate of $3 billion. Henry Schein had a net margin of 3.37% and a return on equity of 14.03%. The company’s revenue for the quarter was down 10.5% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.21 earnings per share. On average, analysts expect Henry Schein to post $5 EPS for the current fiscal year and $6 EPS for the next fiscal year.

Henry Schein Price Performance

Henry Schein stock opened at $67.78 on Friday. The business has a 50 day simple moving average of $73.46 and a 200 day simple moving average of $72.31. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.67 and a quick ratio of 1.00. The company has a market capitalization of $8.71 billion, a PE ratio of 21.52, a price-to-earnings-growth ratio of 1.70 and a beta of 0.87. Henry Schein has a one year low of $60.01 and a one year high of $82.63.

Insider Transactions at Henry Schein

In related news, CEO Bradford C. Connett sold 6,430 shares of Henry Schein stock in a transaction dated Wednesday, March 20th. The stock was sold at an average price of $74.28, for a total value of $477,620.40. Following the completion of the sale, the chief executive officer now directly owns 73,108 shares in the company, valued at $5,430,462.24. The sale was disclosed in a filing with the SEC, which is available through the SEC website. In related news, Vice Chairman James P. Breslawski sold 2,907 shares of Henry Schein stock in a transaction on Monday, March 18th. The stock was sold at an average price of $74.37, for a total transaction of $216,193.59. Following the completion of the sale, the insider now directly owns 209,562 shares of the company’s stock, valued at $15,585,125.94. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, CEO Bradford C. Connett sold 6,430 shares of the stock in a transaction dated Wednesday, March 20th. The shares were sold at an average price of $74.28, for a total value of $477,620.40. Following the completion of the transaction, the chief executive officer now directly owns 73,108 shares in the company, valued at approximately $5,430,462.24. The disclosure for this sale can be found here. 1.14% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

A number of research analysts have issued reports on HSIC shares. Piper Sandler lifted their price objective on Henry Schein from $78.00 to $86.00 and gave the company an “overweight” rating in a report on Monday, February 26th. Evercore ISI boosted their price target on shares of Henry Schein from $79.00 to $83.00 and gave the company an “in-line” rating in a research report on Wednesday, February 28th. Leerink Partnrs reaffirmed a “market perform” rating on shares of Henry Schein in a report on Monday, February 26th. JPMorgan Chase & Co. boosted their target price on Henry Schein from $82.00 to $88.00 and gave the stock an “overweight” rating in a report on Wednesday, March 6th. Finally, SVB Leerink initiated coverage on Henry Schein in a research report on Monday, February 26th. They set a “market perform” rating and a $78.00 price target on the stock. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $81.09.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.